Skip to main content
MedPathMedPath Home
Clinical Trials/NCT01013233
NCT01013233
Unknown
Not Applicable

Training of Cognitive Function of Patients After Chemotherapy

Charite University, Berlin, Germany1 site in 1 country20 target enrollmentDecember 2009
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsCognitive Dysfunction

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Cognitive Dysfunction
Sponsor
Charite University, Berlin, Germany
Enrollment
20
Locations
1
Primary Endpoint
several cognitive tests (TAP, VLMT, TMT, Stroop, RWT, D2, LGT-3)
Last Updated
16 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSitesSimilar Trials

Overview

Brief Summary

The purpose of this study is to improve cognitive dysfunction following chemotherapy, the investigators investigated to see whether a cognitive training for memory and concentration skills can improve cognitive performance in patients following cancer treatment.

Detailed Description

Patients following chemotherapy invited for a cognitive training. Before and after cognitive function will evaluate.

Registry
clinicaltrials.gov
Start Date
December 2009
End Date
October 2011
Last Updated
16 years ago
Study Type
Interventional
Study Design
Crossover
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • •patients with cancer 6 weeks after chemotherapy

Exclusion Criteria

  • •patients with neurological or psychiatric disorders
  • •patients without compliance

Outcomes

Primary Outcomes

several cognitive tests (TAP, VLMT, TMT, Stroop, RWT, D2, LGT-3)

Time Frame: one weeks following the end of the cognitive training

Secondary Outcomes

  • quality of life and subjective perception of cognitive problems(7 weeks)

Study Sites (1)

Loading locations...

Similar Trials

Completed
Not Applicable
An Investigation of Chemotherapy Induced Cognitive Impairments in Breast Cancer SurvivorsBreast Cancer
NCT02515487NYU Langone Health11
Completed
Not Applicable
Treating Verbal Memory Deficits Following Chemotherapy for Breast CancerBreast Cancer TreatmentCognitive Deficits
NCT03017560Northwestern University45
Completed
Phase 2
The Activity Intervention for ChemobrainCancerChemotherapyCognitive Impairment
NCT00495703Vanderbilt University Medical Center64
Completed
Not Applicable
Cognitive Changes in Adult Cancer SurvivorsCognitive ImpairmentEffects of Chemotherapy
NCT01569932Washington University School of Medicine13
Withdrawn
Early Phase 1
Fluoxetine Prevention TrialCognitive Dysfunction
NCT01615055University of California, Los Angeles